Latest Breaking News On - Hedge funds weigh in on health catalyst - Page 1 : comparemela.com

Health Catalyst (NASDAQ:HCAT) Price Target Cut to $13 00 by Analysts at Wells Fargo & Company

Health Catalyst (NASDAQ:HCAT) Price Target Cut to $13 00 by Analysts at Wells Fargo & Company
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesPiper sandlerHealth catalyst trading downHedge funds weigh in on health catalystVanguard group incImpax asset management groupNews ratings for health catalyst dailyCantor fitzgeraldAnalyst recommendations for health catalystYork mellon corpNepsis incCanaccord genuity groupWells fargo companyHealth catalyst incHealth catalystPrimecap management co

Health Catalyst, Inc (NASDAQ:HCAT) Insider Sells $12,250 55 in Stock

Health Catalyst, Inc (NASDAQ:HCAT) Insider Sells $12,250 55 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesPiper sandlerLinda llewelynHealth catalyst price performanceNepsis incNews ratings for health catalyst dailyHedge funds weigh in on health catalystLos angeles capital managementCapital partnersGoldman sachs group incPricet rowe associates incQuarter for health catalystHealth catalystHealth catalyst incCantor fitzgerald

Health Catalyst s (HCAT) Overweight Rating Reaffirmed at Cantor Fitzgerald

Health Catalyst (NASDAQ:HCAT – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports. They currently have a $16.00 price objective on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 156.41% from the stock’s previous close. Other research analysts have also […]

United statesLinda llewelynJpmorgan chase coAnalyst recommendations for health catalystInsider activity at health catalystVanguard group incSecurities exchange commissionCanaccord genuity groupHealth catalyst company profileHedge funds weigh in on health catalystHealth catalyst price performanceNews ratings for health catalyst dailyClearbridge investmentsCantor fitzgeraldHealth catalystDimensional fund advisors

Health Catalyst (NASDAQ:HCAT) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $16.00 price target on the stock. A number of other equities analysts also recently commented on the stock. Barclays initiated coverage on shares of Health […]

United statesLinda llewelynAnalyst recommendations for health catalystCanaccord genuity groupJpmorgan chase coNews ratings for health catalyst dailyHealth catalyst incInsider transactions at health catalystCantor fitzgeraldJefferies financial group incBarclays plcHedge funds weigh in on health catalystYork mellon corpHealth catalystShell asset management coHealth catalyst price performance

KeyCorp Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $10 00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by KeyCorp from $12.00 to $10.00 in a research report released on Monday morning, Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research firms have also weighed in on HCAT. Guggenheim upgraded shares of Health Catalyst […]

United statesLinda llewelynCanaccord genuity groupNews ratings for health catalyst dailyPricet rowe associates incHedge funds weigh in on health catalystVident advisoryCapital partnersHealth catalyst incNuveen asset managementHealth catalyst stock downHealth catalyst company profileHealth catalystJpmorgan chase coAnalyst recommendations for health catalystBarclays plc